Literature DB >> 23570727

The neuroprotective mechanism of puerarin treatment of acute spinal cord injury in rats.

Feng Tian1, Li-Hui Xu, Wei Zhao, Li-Jie Tian, Xiang-Lu Ji.   

Abstract

Puerarin extracted from radix puraeriae is shown to exert a variety of pharmacological effects including neuroprotective properties. However, its mechanisms of action are needed to further explore. The study was designed to investigate the mechanism of puerarin treatment of acute spinal cord ischemia-reperfusion injury (SCI/RI) in rats. SCI/RI was conducted in male Sprague-Dawley rats, and 50mg/kg of puerarin was injected intraperitoneally at 1, 2, 4 and 6h after reperfusion, followed by the same dose of injection every 24h for 2 days. Glutamate level, metabotropic glutamate receptors (mGluR) mRNA expression, and apoptosis indices were examined. Neurologic function was assessed at 48 h of reperfusion. SCI/RI caused extensive motor deficit associated with an elevation of glutamate level and mGluRs-1 mRNA expression, while puerarin administration improved motor deficit, and decreased glutamate level and inhibited mGluRs-1 mRNA expression. The present study demonstrated that administration of puerarin reduced the spinal ischemia/reperfusion injury, and suggested that the neuroprotective mechanism of puerarin involved a decrease in glutamate release and mGluRs-1 mRNA expression.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23570727     DOI: 10.1016/j.neulet.2013.03.039

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Quercetin suppresses NLRP3 inflammasome activation and attenuates histopathology in a rat model of spinal cord injury.

Authors:  W Jiang; Y Huang; N Han; F He; M Li; Z Bian; J Liu; T Sun; L Zhu
Journal:  Spinal Cord       Date:  2016-01-12       Impact factor: 2.772

2.  Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update.

Authors:  Chao-Chao Yu; Yan-Jun Du; Jin Li; Yi Li; Li Wang; Li-Hong Kong; Ying-Wen Zhang
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

3.  Puerarin protects brain tissue against cerebral ischemia/reperfusion injury by inhibiting the inflammatory response.

Authors:  Feng Zhou; Liang Wang; Panpan Liu; Weiwei Hu; Xiangdong Zhu; Hong Shen; Yuanyuan Yao
Journal:  Neural Regen Res       Date:  2014-12-01       Impact factor: 5.135

4.  Puerarin Attenuates Oxidative Stress and Ferroptosis via AMPK/PGC1α/Nrf2 Pathway after Subarachnoid Hemorrhage in Rats.

Authors:  Yi Huang; Honggang Wu; Yongmei Hu; Chenhui Zhou; Jiawei Wu; Yiwen Wu; Haifeng Wang; Cameron Lenahan; Lei Huang; Sheng Nie; Xiang Gao; Jie Sun
Journal:  Antioxidants (Basel)       Date:  2022-06-27

5.  Polyphenolic grape stalk and coffee extracts attenuate spinal cord injury-induced neuropathic pain development in ICR-CD1 female mice.

Authors:  Anna Bagó-Mas; Andrea Korimová; Meritxell Deulofeu; Enrique Verdú; Núria Fiol; Viktorie Svobodová; Petr Dubový; Pere Boadas-Vaello
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

Review 6.  Puerarin: A protective drug against ischemia-reperfusion injury.

Authors:  Minglang Gao; Ziyao Zhang; Kai Lai; Yu Deng; Chuanbing Zhao; Zilong Lu; Qing Geng
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

Review 7.  Therapeutic Effects of Traditional Chinese Medicine on Spinal Cord Injury: A Promising Supplementary Treatment in Future.

Authors:  Qian Zhang; Hao Yang; Jing An; Rui Zhang; Bo Chen; Ding-Jun Hao
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-28       Impact factor: 2.629

8.  Puerarin attenuates intracerebral hemorrhage-induced early brain injury possibly by PI3K/Akt signal activation-mediated suppression of NF-κB pathway.

Authors:  Jun Zeng; Shizhong Zheng; Yizhao Chen; Yaoming Qu; Jiayu Xie; Enhui Hong; Hongzhu Lv; Rui Ding; Liang Feng; Zhichong Xie
Journal:  J Cell Mol Med       Date:  2021-06-27       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.